The role of the mind in dis-ease
We hear from emotional trauma expert and renowned healer, Antonia Harman about the role of the mind in dis-ease.
The Johnson & Johnson COVID vaccine works with just one dose
The New Jersey-based drugmaker created a COVID-19 vaccine that works at 66% efficiency in one dose, which they have sent to the EU for approval.
COVID-19: Surge in the use of NHS tech in 2020
Ben Davison, NHS Digital’s Executive Director for Product Development, explains how the coronavirus pandemic prompts a surge in the number of people using NHS tech in 2020.
School children to be offered two COVID tests a week after lockdown
A leaked plan for the re-opening of schools lists a measure to provide two COVID tests a week, to school children who have returned to education.
The priorities to increase global climate ambition
Open Access Government spoke to Oliver Bolton, CEO of Earthly about the priorities to increase global climate ambition in line with the Paris Agreement.
Is the UK heading for a “perfect storm” of diabetes referrals?
Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.
Japan’s efforts toward increasing the use of hydrogen energy
Maiko Shimmura, from the New Energy and Industrial Technology Development Organization (NEDO), details Japan’s efforts toward increasing the use of hydrogen energy.
Can pubs effectively prevent COVID-19 transmission risk?
A new study has questioned whether pub operators can effectively and consistently prevent COVID-19 transmission risk.
New contraception guidelines for the COVID-19 pandemic
Dr Deborah Lee, Dr Fox Online Pharmacy, clarifies everything you need to know about using and accessing contraception during the COVID-19 pandemic.
How does the Off-Payroll legislation effect umbrella companies?
Crawford Temple, CEO and founder of Professional Passport, outlines what an umbrella company is and how the umbrella model works with reference to the Off-Payroll legislation changes.
The Habsburg Empire: Is the nation-state national and the empire imperial?
Gábor Egry, Director-General at the Institute of Political History and principal investigator of Horizon 2020 funded project NEPOSTRANS, dissects the ideologies that shaped and outlived the Habsburg Empire.
How TECS have supported the NHS pre, during and post-COVID
Zillah Moore, Director at Tunstall Healthcare, discusses the role of technology-enabled care services and remote patient monitoring in reducing delayed discharge from hospitals and providing much-needed assistance to the NHS.
Heart failure drug may treat COVID-19 long-hauler symptom
Researchers have found that an existing heart failure drug can improve the symptoms associated with postural orthostatic tachycardia syndrome.
70% of available COVID vaccines in 2021 have been pre-ordered
Currently, 16% of the global population have pre-ordered 70% of available COVID vaccines in 2021 - a group of virus experts now warn that COVID will keep evolving unless low income countries can access vaccines.
Nanostructured materials offer efficient thermoelectric energy harvesting
Professor Neophytos Neophytou sheds some light on nanostructures and explains how the Horizon 2020 NANOthermMA project could eventually enable a strong boost in thermoelectric technology.
Managing debt collection in the wake of the pandemic
Brian Holden, Global Director of Financial Services at SAS UK & Ireland, explores the potential of the UK Government managing debt collection in the wake of the pandemic.
Existing drugs could be used to fight COVID-19 in elderly patients
A research team at MIT have created a machine-learning strategy to identify existing drugs that could be repurposed to fight COVID-19 in elderly patients.
Causes and progression of vascular dementia
Helen Green, Dementia Specialist Nurse on Dementia UK’s Admiral Nurse Dementia Helpline, charts the causes and progression of vascular dementia.
UK invests £10 million in a new national green finance research centre
The UK is investing £10 million in a new national green finance research centre that will advise lenders, investors and insurers to make environmentally sustainable decisions.
How will everyone benefit if WTO members sign the TRIPS COVID-19 waiver?
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the TRIPS COVID-19 waiver rejected by the WTO could ramp up global vaccine production.